Add-on Therapy
<p>Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials</p>
... as add-on therapy to insulin in T2DM ...insulin therapy in T2DM patients, these two studies are with certain methodological fl ...as add-on therapy to insulin in T2DM ...combined ...
14
Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review
... different add-on therapies and to explore the effect of more than one add- on therapy in patients with more severe asthma as well as in those having symptoms but not significant bronchodi- lator ...
25
Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
... statin therapy for treating dyslipidemia could slow the progression of renal ...diet therapy and statin add-on therapy, or to determine the clinical target of serum low-density lipoprotein ...
9
Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen
... adjunctive therapy, added to the administration of an anti-inflammatory/ analgesic drug and based on lipoic acid and curcumin, in patients with a diagnosis of lumbar sciatica, lumbar disc herniation and/or lumbar ...
7
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
... tiotropium add-on to at least ICS maintenance therapy have been performed in adult patients across all severities of symptomatic ...an add-on to high-dose ICS plus a LABA over 48 ...tiotropium ...
11
Third Generation Antipsychotic as add-on therapy in Intractable Obsessive-Compulsive Disorder
... In the course of the evaluation, while the appraiser was uninformed regarding the prearranged add-on therapy, all cases took incessantly their existing SRIs at the extreme dosage throughout trial. ...
5
Oxcarbazepine effectiveness as add-on therapy in Bulgarian patients with drug-resistant epilepsy
... and add-on therapy in children and adult patients with focal seizures with or without evolution to bilateral tonic-clonic seizures and with generalized tonic-clonic ...
10
Efficacy and Safety of Canagliflozin as Add-On Therapy to Metformin in Type 2 Diabetes
... As add-on therapy to metformin, canagliflozin 100 mg is noninferior and canagliflozin 300 mg is superior to glimepiride and sita- gliptin over 52 ...
6
<p>SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients</p>
... as add-on ...an add-on treatment to metformin monotherapy in patients with T2DM, is similar in Asian versus non-Asian patients, despite known ethnic differences in phenotype and pathophysiology of ...
15
Efficacy and Safety of Canagliflozin Compared to Sitagliptin and Glimepride as Add- on Therapy in T2DM
... pharmacological therapy for type ...of therapy (p= ...effective add-on therapy with metformin for proper control of blood glucose in ...
11
Lamotrigine: how effective is it as add-on therapy in Bulgarian patients with drug-resistant epilepsy
... 110 respondersʹ percentage and seizure severity improvement have been reported in patients with focal epilepsy, as well as 50% and 33% of respondersʹ percentage in patients with generalized tonic-clonic seizures and ...
13
Cilostazol as an add-on therapy for patients with Alzheimer’s disease in Taiwan: a case control study
... Methods: We explored the therapeutic responses by using a case – control study, which was conducted in Taiwan. We enrolled 30 participants with stable AD who were receiving cilostazol (50 mg) twice per day as an ...
6
Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥65 years) with type 2 diabetes
... This analysis is unique in that it focuses on the long-term (up to 206 weeks) safety of saxagliptin in older patients, but it has limitations. This was a retrospective analysis, and the small number of patients reporting ...
9
EFFICACY AND SAFETY OF TENELIGLIPTIN AS ADD ON THERAPY TO CONVENTIONAL THERAPY IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS
... conventional therapy. There is a need for effective add-on therapy like DPP-4 inhibitors besides existing standard therapy (metformin, glimepiride) to prevent uncontrolled diabetes and ...
5
Lixisenatide as add-on therapy to basal insulin
... All three studies demonstrated a significant decrease in both HbA 1c levels and insulin dose requirement with lixisenatide compared with placebo as add-on therapy to basal insulin. This allowed ...
14
Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
... as add-on therapy to insulin has a favorable safety and tolerability profile in patients with renal ...background therapy was not ...as add-on therapy to insulin in patients with renal ...
14
Evaluation of Safety and Efficacy of Collagen Peptide as an Add on Therapy to Standard Treatment in Comparison with the Standard Treatment alone in the Management of Patients with Knee Joint Osteoarthritis
... AN ADD ON THERAPY TO STANDARD TREATMENT IN COMPARISON WITH THE STANDARD TREATMENT ALONE IN THE MANAGEMENT OF PATIENTS WITH KNEE JOINT OSTEOARTHRITIS” submitted by ...
140
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
... current therapy for hypercholesterolemia, ezetimibe may be the most powerful agent to improve the LDL/HDL ratio compared to any statin ...ezetimibe add-on therapy significantly reduced the ratio of ...
8
Which thiazide to choose as add-on therapy for hypertension?
... Combined therapy is required in the majority of patients with hypertension to achieve blood pressure (BP) ...as add-on therapy effectively reduce BP levels, the majority of studies have obtained ...
13
Efficacy and Safety of Saxagliptin as Add-On Therapy in Type 2 Diabetes
... Combination therapy using agents with complementary but different mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of combined antihy- ...
8